REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-RezLondon Stock Exchange·2 days ago, 05:06 AMGSK-2.23%03692-3.52%
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?benzinga_article·Jul 24 at 05:25 AMAMPH-1.90%ANIP-1.69%
Yili Chuanning Bio: Net profit in the third quarter was 157 million yuan, a year-on-year decrease of 49.44%Zhitong·Oct 27, 2025 at 05:33 AM301301+0.93%
Yili Chuanning Bio has been approved to register 1 billion yuan medium-term notesZhitong·Sep 11, 2025 at 10:54 PM301301+0.93%
KELUN PHARMA: With the arrival of the peak season in the fourth quarter, Yili Chuanning Bio's performance is expected to improveZhitong·Aug 31, 2025 at 10:03 PM002422-0.58%301301+0.93%
Yili Chuanning Bio: In the first half of the year, the net profit attributable to the parent company was 455 million yuan, a year-on-year decrease of 40.64%Zhitong·Aug 25, 2025 at 06:53 AM301301+0.93%
Overview of A-share restricted stock unlock: Restricted stocks worth 488 million yuan are unlocked todayZhitong·May 29, 2025 at 06:36 PM301301+0.93%300553-10.72%
A-shares closing: The ChiNext index fell nearly 2% on reduced volume, while the synthetic biology concept surged against the trendWallstreetcn·May 15, 2025 at 02:02 AM301108-1.14%603630-1.12%
Synthetic biology concept stocks fluctuated and rose, Yili Chuanning Bio hit a 20% limit upZhitong·May 14, 2025 at 08:55 PM301301+0.93%002626+2.31%
Yili Chuanning Bio: 2024 net profit is expected to grow by 48.88% year-on-yearZhitong·Apr 21, 2025 at 08:22 AM301301+0.93%
